BioSpace News Archive

“I thought that patients in hospitals and nursing homes needed a better way to stay comfortable in bed while they recovered,” said an inventor from Pleasanton, Texas. “This led me to develop a better set of sheets that helps keep the pillow in the proper position.”

As documented in numerous surveys over the last decade, the changing face of medicine has resulted in career burnout so intense that many physicians retire early, mid-life physicians question their calling and younger generations avoid entering the field.

Today, Dr. Gigi Osler, an otolaryngology-head and neck surgeon from Winnipeg became the President of the Canadian Medical Association.

For the second time in a row, the National Cancer Institute has awarded St. Jude Children’s Research Hospital the highest possible rank of “exceptional” and the best numerical score in the hospital’s history during the renewal of the hospital’s $36 million Comprehensive Cancer Center grant.

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies, today announced the Company will be participating in the following upcoming investor conferences:

Varian, (NYSE: VAR) today announced its fourth quarter fiscal year 2018 earnings release date and upcoming investor meeting at the American Society for Radiation Oncology (ASTRO) Annual Meeting.

During its September Spotlight on Malnutrition, the Academy of Nutrition and Dietetics will raise awareness of malnutrition, promote the crucial role of registered dietitian nutritionists in identifying and treating this serious medical condition, and provide educational resources for the public and Academy members.

Medpace Holdings, Inc. announced a secondary offering of 5,224,997 shares of its common stock by investment funds affiliated with Cinven Capital Management (V) General Partner Limited

BD (Becton, Dickinson and Company) announced today that it will present at the Wells Fargo Securities 2018 Healthcare Conference on Wednesday, September 5, 2018, at 3:00 PM ET.

AVITA Medical today announced the successful completion of multiple production runs for the RECELL Device® within its newly acquired manufacturing facility in Ventura, California.